Sign in
4

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-22-029453

Chief Operating Officer bought 20,000 shares at $8.16 ($163,288)

From the SEC's structured data for this filing

Trades in this filing

Nabulsi Azmi · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-05-16 Purchase : show line 1 in the form +20,000 $8.16 $163,288 785,700 I
Open-market purchases · 20,000 sh · avg $8.16 · $163,288
Loading xslF345X03/doc4.xml…